Purinergic neurone-glia signalling in cognitive-related pathologies

Neuropharmacology

Volumn 104, Issue , 2016, Pages 62-75

  Illes, Peter ^a   Verkhratsky, Alexei ^b,c,d,e  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c BASQUE FOUNDATION FOR SCIENCE   (Spain)

^d UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^e LOBACHEVSKY STATE UNIVERSITY OF NIZHNY NOVGOROD   (Russian Federation)

Author keywords

Astrocyte; Cognition; Dementia; Microglia; Neurodegeneration; Neuropsychiatric diseases; Oligodendrocyte; Purinergic signalling; Purinoceptors

Indexed keywords

ADENOSINE TRIPHOSPHATE; PURINERGIC P2X4 RECEPTOR; PURINERGIC P2X7 RECEPTOR; PURINERGIC P2Y1 RECEPTOR; PURINERGIC P2Y12 RECEPTOR; PURINERGIC P2Y2 RECEPTOR; PURINERGIC P2Y6 RECEPTOR; PURINERGIC RECEPTOR; PURINERGIC P2X RECEPTOR; PURINERGIC P2Y RECEPTOR;

ADDICTION; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ASTROCYTOSIS; BRAIN HYPOXIA; BRAIN TOXICITY; CEREBROVASCULAR ACCIDENT; COGNITIVE DEFECT; DEMENTIA; EPILEPSY; GLIA; GLIA CELL; HIPPOCAMPUS; HUMAN; HUNTINGTON CHOREA; KORSAKOFF PSYCHOSIS; MACROGLIA; MAJOR DEPRESSION; MICROGLIA; MOOD DISORDER; MULTIPLE SCLEROSIS; NEUROPATHOLOGY; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; SPINAL CORD INJURY; STAB WOUND; TRAUMATIC BRAIN INJURY; ANIMAL; BRAIN; DEGENERATIVE DISEASE; METABOLISM; NERVE CELL; PSYCHOLOGY;

ADENOSINE TRIPHOSPHATE; ANIMALS; BRAIN; COGNITION DISORDERS; HUMANS; NEURODEGENERATIVE DISEASES; NEUROGLIA; NEURONS; RECEPTORS, PURINERGIC P2X; RECEPTORS, PURINERGIC P2Y; SIGNAL TRANSDUCTION;

EID: 84968779598     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2015.08.005     Document Type: Review

References (231)

1. M.P. Abbracchio, G. Burnstock, A. Verkhratsky, and H. Zimmermann Purinergic signalling in the nervous system: an overview Trends Neurosci. 32 2009 19 29
2. E. Adinolfi, M. Cirillo, R. Woltersdorf, S. Falzoni, P. Chiozzi, P. Pellegatti, M.G. Callegari, D. Sandona, F. Markwardt, G. Schmalzing, and F. Di Virgilio Trophic activity of a naturally occurring truncated isoform of the P2X7 receptor FASEB J. 24 2010 3393 3404
3. 12 receptor protein in cortical gray matter lesions in multiple sclerosis Cereb. Cortex 20 2010 1263 1273
4. A. Araque, V. Parpura, R.P. Sanzgiri, and P.G. Haydon Tripartite synapses: glia, the unacknowledged partner Trends Neurosci. 22 1999 208 215
5. A. Araque, G. Carmignoto, P.G. Haydon, S.H. Oliet, R. Robitaille, and A. Volterra Gliotransmitters travel in time and space Neuron 81 2014 728 739
6. 7 receptor blockade prevents ATP excitotoxicity in neurons and reduces brain damage after ischemia Neurobiol. Dis. 45 2012 954 961
7. V. Armstrong, C.M. Reichel, J.F. Doti, C.A. Crawford, and S.A. McDougall Repeated amphetamine treatment causes a persistent elevation of glial fibrillary acidic protein in the caudate-putamen Eur. J. Pharmacol. 488 2004 111 115
8. I. Arnoux, M. Hoshiko, L. Mandavy, E. Avignone, N. Yamamoto, and E. Audinat Adaptive phenotype of microglial cells during the normal postnatal development of the somatosensory "Barrel" cortex Glia 61 2013 1582 1594
9. 1 subunit J. Neurochem. 113 2010 1676 1684
10. 7 receptors in cerebral ischemia Neurosci. Bull. 29 2013 390 398
11. M. Barbierato, L. Facci, C. Argentini, C. Marinelli, S.D. Skaper, and P. Giusti Astrocyte-microglia cooperation in the expression of a pro-inflammatory phenotype CNS Neurol. Disord. Drug Targets 12 2013 608 618
12. K. Barley, S. Dracheva, and W. Byne Subcortical oligodendrocyte- and astrocyte-associated gene expression in subjects with schizophrenia, major depression and bipolar disorder Schizophr. Res. 112 2009 54 64
13. 7 receptor knockout mice in animal models of depression and anxiety: relevance for neuropsychiatric disorders Behav. Brain Res. 198 2009 83 90
14. J. Beauquis, P. Pavia, C. Pomilio, A. Vinuesa, N. Podlutskaya, V. Galvan, and F. Saravia Environmental enrichment prevents astroglial pathological changes in the hippocampus of APP transgenic mice, model of Alzheimer's disease Exp. Neurol. 239 2013 28 37
15. J. Beauquis, A. Vinuesa, C. Pomilio, P. Pavia, V. Galvan, and F. Saravia Neuronal and glial alterations, increased anxiety, and cognitive impairment before hippocampal amyloid deposition in PDAPP mice, model of Alzheimer's disease Hippocampus 24 2014 257 269
16. M.V. Bennett, J.M. Garre, J.A. Orellana, F.F. Bukauskas, M. Nedergaard, and J.C. Saez Connexin and pannexin hemichannels in inflammatory responses of glia and neurons Brain Res. 1487 2012 3 15
17. R. Bernard, I.A. Kerman, R.C. Thompson, E.G. Jones, W.E. Bunney, J.D. Barchas, A.F. Schatzberg, R.M. Myers, H. Akil, and S.J. Watson Altered expression of glutamate signaling, growth factor, and glia genes in the locus coeruleus of patients with major depression Mol. Psychiatry 16 2011 634 646
18. T. Blank, and M. Prinz Microglia as modulators of cognition and neuropsychiatric disorders Glia 61 2013 62 70
19. H. Braak, R.A. de Vos, E.N. Jansen, H. Bratzke, and E. Braak Neuropathological hallmarks of Alzheimer's and Parkinson's diseases Prog. Brain Res. 117 1998 267 285
20. M. Bradl, and H. Lassmann Oligodendrocytes: biology and pathology Acta Neuropathol. 119 2010 37 53
21. R.J. Bridges, N.R. Natale, and S.A. Patel System xc(-) cystine/glutamate antiporter: an update on molecular pharmacology and roles within the CNS Br. J. Pharmacol. 165 2012 20 34
22. 7 receptor channels allow direct permeation of nanometer-sized dyes J. Neurosci. 33 2013 3557 3566
23. J.E. Burda, A.M. Bernstein, and M.V. Sofroniew Astrocyte roles in traumatic brain injury Exp. Neurol. 2015 10.1016/j.expneurol.2015.03.020 E-pub ahead of print
24. J.E. Burda, and M.V. Sofroniew Reactive gliosis and the multicellular response to CNS damage and disease Neuron 81 2014 229 248
25. G. Burnstock, U. Krugel, M.P. Abbracchio, and P. Illes Purinergic signalling: from normal behaviour to pathological brain function Prog. Neurobiol. 95 2011 229 274
26. G. Burnstock, and A. Verkhratsky Evolutionary origins of the purinergic signalling system Acta Physiol. (Oxf) 195 2009 415 447
27. G. Burnstock, and A. Verkhratsky Purinergic Signalling and the Nervous System 2012 Springer Heidelberg
28. A.M. Butt ATP: a ubiquitous gliotransmitter integrating neuron-glial networks Semin. Cell Dev. Biol. 22 2011 205 213
29. X. Cao, L.P. Li, Q. Wang, Q. Wu, H.H. Hu, M. Zhang, Y.Y. Fang, J. Zhang, S.J. Li, W.C. Xiong, H.C. Yan, Y.B. Gao, J.H. Liu, X.W. Li, L.R. Sun, Y.N. Zeng, X.H. Zhu, and T.M. Gao Astrocyte-derived ATP modulates depressive-like behaviors Nat. Med. 19 2013 773 777
30. M.R. Carmo, A.P. Menezes, A.C. Nunes, A. Pliassova, A.P. Rolo, C.M. Palmeira, R.A. Cunha, P.M. Canas, and G.M. Andrade The P2X7 receptor antagonist Brilliant Blue G attenuates contralateral rotations in a rat model of Parkinsonism through a combined control of synaptotoxicity, neurotoxicity and gliosis Neuropharmacology 81 2014 142 152
31. R.J. Castellani, and M.A. Smith Compounding artefacts with uncertainty, and an amyloid cascade hypothesis that is 'too big to fail' J. Pathol. 224 2011 147 152
32. J. Chen, Z. Tan, L. Zeng, X. Zhang, Y. He, W. Gao, X. Wu, Y. Li, B. Bu, W. Wang, and S. Duan Heterosynaptic long-term depression mediated by ATP released from astrocytes Glia 61 2013 178 191
33. 1 receptors in cognitive deficit after focal cerebral stroke in a rodent model J. Neuroinflammation 10 2013 95
34. A.M. Choo, W.J. Miller, Y.C. Chen, P. Nibley, T.P. Patel, C. Goletiani, B. Morrison 3rd, M.K. Kutzing, B.L. Firestein, J.Y. Sul, P.G. Haydon, and D.F. Meaney Antagonism of purinergic signalling improves recovery from traumatic brain injury Brain 136 2013 65 80
35. 7 receptor ameliorates transient global cerebral ischemia/reperfusion injury via modulating inflammatory responses in the rat hippocampus J. Neuroinflammation 9 2012 69
36. L.E. Clarke, and B.A. Barres Emerging roles of astrocytes in neural circuit development Nat. Rev. Neurosci. 14 2013 311 321
37. J. Clasadonte, J. Dong, D.J. Hines, and P.G. Haydon Astrocyte control of synaptic NMDA receptors contributes to the progressive development of temporal lobe epilepsy Proc. Natl. Acad. Sci. U. S. A. 110 2013 17540 17545
38. 7 receptor: treasure hunting Purinergic Signal 7 2011 7 19
39. A.H. Crawford, J.H. Stockley, R.B. Tripathi, W.D. Richardson, and R.J. Franklin Oligodendrocyte progenitors: adult stem cells of the central nervous system? Exp. Neurol. 260 2014 50 55
40. 7) on non-haematopoietic cells leads to selective alteration in mood-related behaviour with dysregulated gene expression and stress reactivity in mice Int. J. Neuropsychopharmacol. 16 2013 213 233
41. G. Csordas, and G. Hajnoczky SR/ER-mitochondrial local communication: calcium and ROS Biochim. Biophys. Acta 1787 2009 1352 1362
42. N. D'Ambrosi, P. Finocchi, S. Apolloni, M. Cozzolino, A. Ferri, V. Padovano, G. Pietrini, M.T. Carri, and C. Volonte The proinflammatory action of microglial P2 receptors is enhanced in SOD1 models for amyotrophic lateral sclerosis J. Immunol. 183 2009 4648 4656
43. M. De Pitta, N. Brunel, and A. Volterra Astrocytes: orchestrating synaptic plasticity? Neuroscience 2015 10.1016/j.neuroscience.2015.04.001 E-pub ahead of print
44. A. Del Puerto, F. Wandosell, and J.J. Garrido Neuronal and glial purinergic receptors functions in neuron development and brain disease Front. Cell Neurosci. 7 2013 197
45. 7 triggers alpha-secretase-dependent processing of the amyloid precursor protein J. Biol. Chem. 286 2011 2596 2606
46. 1 receptor signalling mediates astrocytic hyperactivity in vivo in an Alzheimer's disease mouse model Nat. Commun. 5 2014 5422
47. F. Di Virgilio P2X receptors and inflammation Curr. Med. Chem. 22 2015 866 877
48. 7 receptors mediate ischemic damage to oligodendrocytes Glia 58 2010 730 740
49. Y. Dou, H.J. Wu, H.Q. Li, S. Qin, Y.E. Wang, J. Li, H.F. Lou, Z. Chen, X.M. Li, Q.M. Luo, and S. Duan Microglial migration mediated by ATP-induced ATP release from lysosomes Cell Res. 22 2012 1022 1033
50. 7 receptor regulation of non-classical secretion from immune effector cells Cell Microbiol. 14 2012 1697 1706
51. N. Edgar, and E. Sibille A putative functional role for oligodendrocytes in mood regulation Transl. Psychiatry 2 2012 e109
52. B. Emery Regulation of oligodendrocyte differentiation and myelination Science 330 2010 779 782
53. 7 receptor during status epilepticus in mice FASEB J. 26 2012 1616 1628
54. M. Faideau, J. Kim, K. Cormier, R. Gilmore, M. Welch, G. Auregan, N. Dufour, M. Guillermier, E. Brouillet, P. Hantraye, N. Deglon, R.J. Ferrante, and G. Bonvento In vivo expression of polyglutamine-expanded huntingtin by mouse striatal astrocytes impairs glutamate transport: a correlation with Huntington's disease subjects Hum. Mol. Genet. 19 2010 3053 3067
55. A. Faroni, S.W. Rothwell, A.A. Grolla, G. Terenghi, V. Magnaghi, and A. Verkhratsky Differentiation of adipose-derived stem cells into Schwann cell phenotype induces expression of P2X receptors that control cell death Cell Death Dis. 4 2013 e743
56. 7 receptors controls myelination in sciatic nerves J. Neurosci. Res. 92 2014 1259 1269
57. L. Fattore, M.C. Puddu, S. Picciau, A. Cappai, W. Fratta, G.P. Serra, and S. Spiga Astroglial in vivo response to cocaine in mouse dentate gyrus: a quantitative and qualitative analysis by confocal microscopy Neuroscience 110 2002 1 6
58. V. Felipo Hepatic encephalopathy: effects of liver failure on brain function Nat. Rev. Neurosci. 14 2013 851 858
59. C. Ficker, K. Rozmer, E. Kato, R.D. Ando, L. Schumann, U. Krugel, H. Franke, B. Sperlagh, T. Riedel, and P. Illes Astrocyte-neuron interaction in the substantia gelatinosa of the spinal cord dorsal horn via P2X7 receptor-mediated release of glutamate and reactive oxygen species Glia 62 2014 1671 1686
60. R.D. Fields White matter in learning, cognition and psychiatric disorders Trends Neurosci. 31 2008 361 370
61. R.D. Fields, A. Araque, H. Johansen-Berg, S.S. Lim, G. Lynch, K.A. Nave, M. Nedergaard, R. Perez, T. Sejnowski, and H. Wake Glial biology in learning and cognition Neuroscientist 20 2014 426 431
62. E. Fieremans, A. Benitez, J.H. Jensen, M.F. Falangola, A. Tabesh, R.L. Deardorff, M.V. Spampinato, J.S. Babb, D.S. Novikov, S.H. Ferris, and J.A. Helpern Novel white matter tract integrity metrics sensitive to Alzheimer disease progression Am. J. Neuroradiol. 34 2013 2105 2112
63. H. Franke, and P. Illes Nucleotide signaling in astrogliosis Neurosci. Lett. 565 2014 14 22
64. H. Franke, and P. Illes Pathological potential of astroglial purinergic receptors Adv. Neurobiol. 11 2014 213 256
65. H. Franke, A. Verkhratsky, G. Burnstock, and P. Illes Pathophysiology of astroglial purinergic signalling Purinergic Signal 8 2012 629 657
66. T. Fujita, M.J. Chen, B. Li, N.A. Smith, W. Peng, W. Sun, M.J. Toner, B.T. Kress, L. Wang, A. Benraiss, T. Takano, S. Wang, and M. Nedergaard Neuronal transgene expression in dominant-negative SNARE mice J. Neurosci. 34 2014 16594 16604
67. 7 receptor in astrocyte-mediated motor neuron death: implications for amyotrophic lateral sclerosis J. Neuroinflammation 7 2010 33
68. C. Giaume, and X. Liu From a glial syncytium to a more restricted and specific glial networking J. Physiol. Paris 106 2012 34 39
69. F. Ginhoux, S. Lim, G. Hoeffel, D. Low, and T. Huber Origin and differentiation of microglia Front. Cell Neurosci. 7 2013 45
70. A.V. Gourine, V. Kasymov, N. Marina, F. Tang, M.F. Figueiredo, S. Lane, A.G. Teschemacher, K.M. Spyer, K. Deisseroth, and S. Kasparov Astrocytes control breathing through pH-dependent release of ATP Science 329 2010 571 575
71. A.A. Grolla, J.A. Sim, D. Lim, J.J. Rodriguez, A.A. Genazzani, and A. Verkhratsky Amyloid-β and Alzheimer's disease type pathology differentially affects the calcium signalling toolkit in astrocytes from different brain regions Cell Death Dis. 4 2013 e623
72. A. Grosche, T. Pannicke, J. Chen, P. Wiedemann, A. Reichenbach, and A. Bringmann Disruption of endogenous purinergic signaling inhibits vascular endothelial growth factor- and glutamate-induced osmotic volume regulation of Muller glial cells in knockout mice Ophthalmic Res. 50 2013 209 214
73. 7 is a scavenger receptor for apoptotic cells in the absence of its ligand, extracellular ATP J. Immunol. 187 2011 2365 2375
74. 1 receptors inhibit long-term depression in the prefrontal cortex Neuropharmacology 59 2010 406 415
75. N. Haack, P. Dublin, and C.R. Rose Dysbalance of astrocyte calcium under hyperammonemic conditions PLoS One 9 2014 e105832
76. M.M. Halassa, T. Fellin, and P.G. Haydon Tripartite synapses: roles for astrocytic purines in the control of synaptic physiology and behavior Neuropharmacology 57 2009 343 346
77. M.M. Halassa, and P.G. Haydon Integrated brain circuits: astrocytic networks modulate neuronal activity and behavior Annu. Rev. Physiol. 72 2010 335 355
78. N.B. Hamilton, and D. Attwell Do astrocytes really exocytose neurotransmitters? Nat. Rev. Neurosci. 11 2010 227 238
79. U.K. Hanisch, and H. Kettenmann Microglia: active sensor and versatile effector cells in the normal and pathologic brain Nat. Neurosci. 10 2007 1387 1394
80. S. Hashioka, Y.F. Wang, J.P. Little, H.B. Choi, A. Klegeris, P.L. McGeer, and J.G. McLarnon Purinergic responses of calcium-dependent signaling pathways in cultured adult human astrocytes BMC Neurosci. 15 2014 18
81. B. Hassel, S. Tessler, R.L. Faull, and P.C. Emson Glutamate uptake is reduced in prefrontal cortex in Huntington's disease Neurochem. Res. 33 2008 232 237
82. A.S. Hazell Astrocytes are a major target in thiamine deficiency and Wernicke's encephalopathy Neurochem. Int. 55 2009 129 135
83. A.S. Hazell, D. Sheedy, R. Oanea, M. Aghourian, S. Sun, J.Y. Jung, D. Wang, and C. Wang Loss of astrocytic glutamate transporters in Wernicke encephalopathy Glia 58 2009 148 156
84. M.T. Heneka, M.J. Carson, J. El Khoury, G.E. Landreth, F. Brosseron, D.L. Feinstein, A.H. Jacobs, T. Wyss-Coray, J. Vitorica, R.M. Ransohoff, K. Herrup, S.A. Frautschy, B. Finsen, G.C. Brown, A. Verkhratsky, K. Yamanaka, J. Koistinaho, E. Latz, A. Halle, G.C. Petzold, T. Town, D. Morgan, M.L. Shinohara, V.H. Perry, C. Holmes, N.G. Bazan, D.J. Brooks, S. Hunot, B. Joseph, N. Deigendesch, O. Garaschuk, E. Boddeke, C.A. Dinarello, J.C. Breitner, G.M. Cole, D.T. Golenbock, and M.P. Kummer Neuroinflammation in Alzheimer's disease Lancet Neurol. 14 2015 388 405
85. M.T. Heneka, M. Sastre, L. Dumitrescu-Ozimek, I. Dewachter, J. Walter, T. Klockgether, and F. Van Leuven Focal glial activation coincides with increased BACE1 activation and precedes amyloid plaque deposition in APP[V717I] transgenic mice J. Neuroinflammation 2 2005 22
86. L. Hertz, and H.R. Zielke Astrocytic control of glutamatergic activity: astrocytes as stars of the show Trends Neurosci. 27 2004 735 743
87. D.J. Hines, and P.G. Haydon Inhibition of a SNARE-sensitive pathway in astrocytes attenuates damage following stroke J. Neurosci. 33 2013 4234 4240
88. D.J. Hines, L.I. Schmitt, R.M. Hines, S.J. Moss, and P.G. Haydon Antidepressant effects of sleep deprivation require astrocyte-dependent adenosine mediated signaling Transl. Psychiatry 3 2013 e212
89. C. Iadecola, and M. Nedergaard Glial regulation of the cerebral microvasculature Nat. Neurosci. 10 2007 1369 1376
90. P. Illes, A. Verkhratsky, G. Burnstock, and H. Franke P2X receptors and their roles in astroglia in the central and peripheral nervous system Neuroscientist 18 2012 422 438
91. Y. Imura, Y. Morizawa, R. Komatsu, K. Shibata, Y. Shinozaki, H. Kasai, K. Moriishi, Y. Moriyama, and S. Koizumi Microglia release ATP by exocytosis Glia 61 2013 1320 1330
92. 7 receptor antagonist A-438079 Epilepsia 54 2013 1551 1561
93. V. Kasymov, O. Larina, C. Castaldo, N. Marina, M. Patrushev, S. Kasparov, and A.V. Gourine Differential sensitivity of brainstem versus cortical astrocytes to changes in pH reveals functional regional specialization of astroglia J. Neurosci. 33 2013 435 441
94. H. Kettenmann, U.K. Hanisch, M. Noda, and A. Verkhratsky Physiology of microglia Physiol. Rev. 91 2011 461 553
95. H. Kettenmann, F. Kirchhoff, and A. Verkhratsky Microglia: new roles for the synaptic stripper Neuron 77 2013 10 18
96. H. Kettenmann, and B.R. Ransom Neuroglia 2013 Oxford University Press Oxford
97. H. Kettenmann, and A. Verkhratsky Neuroglia: the 150 years after Trends Neurosci. 31 2008 653 659
98. K. Kierdorf, D. Erny, T. Goldmann, V. Sander, C. Schulz, E.G. Perdiguero, P. Wieghofer, A. Heinrich, P. Riemke, C. Holscher, D.N. Muller, B. Luckow, T. Brocker, K. Debowski, G. Fritz, G. Opdenakker, A. Diefenbach, K. Biber, M. Heikenwalder, F. Geissmann, F. Rosenbauer, and M. Prinz Microglia emerge from erythromyeloid precursors via Pu.1- and Irf8-dependent pathways Nat. Neurosci. 16 2013 273 280
99. H.K. Kimelberg, and M. Nedergaard Functions of astrocytes and their potential as therapeutic targets Neurotherapeutics 7 2010 338 353
100. S. Kirischuk, V. Parpura, and A. Verkhratsky Sodium dynamics: another key to astroglial excitability? Trends Neurosci. 35 2012 497 506
101. 1 receptors in the rat medial prefrontal cortex Neuropsychopharmacology 40 2015 305 314
102. S. Koizumi, K. Ohsawa, K. Inoue, and S. Kohsaka Purinergic receptors in microglia: functional modal shifts of microglia mediated by P2 and P1 receptors Glia 61 2013 47 54
103. L. Koles, A. Leichsenring, P. Rubini, and P. Illes P2 receptor signaling in neurons and glial cells of the central nervous system Adv. Pharmacol. 61 2011 441 493
104. A.W. Kraft, X. Hu, H. Yoon, P. Yan, Q. Xiao, Y. Wang, S.C. Gil, J. Brown, U. Wilhelmsson, J.L. Restivo, J.R. Cirrito, D.M. Holtzman, J. Kim, M. Pekny, and J.M. Lee Attenuating astrocyte activation accelerates plaque pathogenesis in APP/PS1 mice FASEB J. 27 2013 187 198
105. U. Krugel, L. Koles, and P. Illes Integration of neuronal and glial signalling by pyramidal cells of the rat prefrontal cortex; control of cognitive functions and addictive behaviour by purinergic mechanisms Neuropsychopharmacol. Hung. 15 2013 206 213
106. 1 receptor is involved in the regulation of cytokine/chemokine transcription and cerebral damage in a rat model of cerebral ischemia J. Cereb. Blood Flow. Metab. 31 2011 1930 1941
107. M. Kulijewicz-Nawrot, A. Verkhratsky, A. Chvatal, E. Sykova, and J.J. Rodriguez Astrocytic cytoskeletal atrophy in the medial prefrontal cortex of a triple transgenic mouse model of Alzheimer's disease J. Anat. 221 2012 252 262
108. U. Lalo, O. Palygin, R.A. North, A. Verkhratsky, and Y. Pankratov Age-dependent remodelling of ionotropic signalling in cortical astroglia Aging Cell 10 2011 392 402
109. U. Lalo, O. Palygin, S. Rasooli-Nejad, J. Andrew, P.G. Haydon, and Y. Pankratov Exocytosis of ATP from astrocytes modulates phasic and tonic inhibition in the neocortex PLoS Biol. 12 2014 e1001747
110. U. Lalo, Y. Pankratov, V. Parpura, and A. Verkhratsky Ionotropic receptors in neuronal-astroglial signalling: what is the role of "excitable" molecules in non-excitable cells Biochim. Biophys. Acta 1813 2011 992 1002
111. 5 subunits form the functional P2X receptor in mouse cortical astrocytes J. Neurosci. 28 2008 5473 5480
112. U. Lalo, A. Verkhratsky, and Y. Pankratov Ionotropic ATP receptors in neuronal-glial communication Semin. Cell Dev. Biol. 22 2011 220 228
113. A.B. Lammer, A. Beck, B. Grummich, A. Forschler, T. Krugel, T. Kahn, D. Schneider, P. Illes, H. Franke, and U. Krugel The P2 receptor antagonist PPADS supports recovery from experimental stroke in vivo PLoS One 6 2011 e19983
114. M. Laruelle Schizophrenia: from dopaminergic to glutamatergic interventions Curr. Opin. Pharmacol. 14 2014 97 102
115. 2+-dependent glutamate release from astrocytes of the BACHD Huntington's disease mouse model Neurobiol. Dis. 58 2013 192 199
116. 7 receptors Neurochem. Int. 62 2013 15 22
117. 2+ signalling and up-regulates expression of TRPC1 gene in astrocytes in primary cultures and in the in vivo brain Neurochem. Res. 39 2014 2127 2135
118. D. Lim, V. Ronco, A.A. Grolla, A. Verkhratsky, and A.A. Genazzani Glial calcium signalling in Alzheimer's disease Rev. Physiol. Biochem. Pharmacol. 167 2014 45 65
119. A. Lima, V.M. Sardinha, A.F. Oliveira, M. Reis, C. Mota, M.A. Silva, F. Marques, J.J. Cerqueira, L. Pinto, N. Sousa, and J.F. Oliveira Astrocyte pathology in the prefrontal cortex impairs the cognitive function of rats Mol. Psychiatry 19 2014 834 841
120. C. Lohr, A. Grosche, A. Reichenbach, and D. Hirnet Purinergic neuron-glia interactions in sensory systems Pflugers Arch. 466 2014 1859 1872
121. 7 purinoceptors contribute to the death of Schwann cells transplanted into the spinal cord Cell Death Dis. 4 2013 e829
122. T.M. Ma, S. Abazyan, B. Abazyan, J. Nomura, C. Yang, S. Seshadri, A. Sawa, S.H. Snyder, and M.V. Pletnikov Pathogenic disruption of DISC1-serine racemase binding elicits schizophrenia-like behavior via D-serine depletion Mol. Psychiatry 18 2013 557 567
123. W. Ma, V. Compan, W. Zheng, E. Martin, R.A. North, A. Verkhratsky, and A. Surprenant Pannexin 1 forms an anion-selective channel Pflugers Arch. 463 2012 585 592
124. 7 receptor antagonist A-438079 J. Neural Transm. 117 2010 681 687
125. H. Markram The blue brain project Nat. Rev. Neurosci. 7 2006 153 160
126. C. Matute Glutamate and ATP signalling in white matter pathology J. Anat. 219 2011 53 64
127. J.J. Miguel-Hidalgo The role of glial cells in drug abuse Curr. Drug Abuse Rev. 2 2009 76 82
128. S. Miyata, T. Hattori, S. Shimizu, A. Ito, and M. Tohyama Disturbance of oligodendrocyte function plays a key role in the pathogenesis of schizophrenia and major depressive disorder Biomed. Res. Int. 2015 2015 492367
129. A.V. Molofsky, R. Krencik, E.M. Ullian, H.H. Tsai, B. Deneen, W.D. Richardson, B.A. Barres, and D.H. Rowitch Astrocytes and disease: a neurodevelopmental perspective Genes Dev. 26 2012 891 907
130. 7R pore J. Neurosci. 29 2009 3781 3791
131. K. Moussawi, A. Riegel, S. Nair, and P.W. Kalivas Extracellular glutamate: functional compartments operate in different concentration ranges Front. Syst. Neurosci. 5 2011 94
132. K.A. Nave, and H. Ehrenreich Myelination and oligodendrocyte functions in psychiatric diseases JAMA Psychiatry 71 2014 582 584
133. M. Nedergaard, and A. Verkhratsky Artifact versus reality-how astrocytes contribute to synaptic events Glia 60 2012 1013 1023
134. E.A. Newman Calcium increases in retinal glial cells evoked by light-induced neuronal activity J. Neurosci. 25 2005 5502 5510
135. 7 receptors in rat cultured neocortical astroglia Br. J. Pharmacol. 160 2010 1941 1952
136. M. Obara-Michlewska, J. Ruszkiewicz, M. Zielinska, A. Verkhratsky, and J. Albrecht Astroglial NMDA receptors inhibit expression of K4.1 channels in glutamate-overexposed astrocytes in vitro and in the brain of rats with acute liver failure Neurochem. Int. 2014 10.1016/j.neuint.2014.10.006 E-pub ahead of print
137. N.A. Oberheim, S.A. Goldman, and M. Nedergaard Heterogeneity of astrocytic form and function Methods Mol. Biol. 814 2012 23 45
138. N.A. Oberheim, X. Wang, S. Goldman, and M. Nedergaard Astrocytic complexity distinguishes the human brain Trends Neurosci. 29 2006 547 553
139. M. Olabarria, H.N. Noristani, A. Verkhratsky, and J.J. Rodriguez Concomitant astroglial atrophy and astrogliosis in a triple transgenic animal model of Alzheimer's disease Glia 58 2010 831 838
140. 7 receptors sensing pathologically high ATP concentrations Cereb. Cortex 21 2011 806 820
141. A. Oliveira, P. Illes, and H. Ulrich Purinergic receptors in embryonic and adult neurogenesis Neuropharmacology 104 2015 272 281
142. 2+ signalling in cortical astrocytes Cell Calcium 48 2010 225 231
143. Y. Pankratov, U. Lalo, A. Verkhratsky, and R.A. North Vesicular release of ATP at central synapses Pflugers Arch. 452 2006 589 597
144. U. Pannasch, and N. Rouach Emerging role for astroglial networks in information processing: from synapse to behavior Trends Neurosci. 36 2013 405 417
145. V. Parpura, M.T. Heneka, V. Montana, S.H. Oliet, A. Schousboe, P.G. Haydon, R.F. Stout Jr., D.C. Spray, A. Reichenbach, T. Pannicke, M. Pekny, M. Pekna, R. Zorec, and A. Verkhratsky Glial cells in (patho)physiology J. Neurochem. 121 2012 4 27
146. + signalling Transl. Neurosci. 3 2012 334 344
147. O. Pascual, K.B. Casper, C. Kubera, J. Zhang, R. Revilla-Sanchez, J.Y. Sul, H. Takano, S.J. Moss, K. McCarthy, and P.G. Haydon Astrocytic purinergic signaling coordinates synaptic networks Science 310 2005 113 116
148. O. Pascual, S. Ben Achour, P. Rostaing, A. Triller, and A. Bessis Microglia activation triggers astrocyte-mediated modulation of excitatory neurotransmission Proc. Natl. Acad. Sci. U. S. A. 109 2012 E197 E205
149. M. Pekna, and M. Pekny The neurobiology of brain injury Cerebrum 2012 2012 9
150. M. Pekny, U. Wilhelmsson, and M. Pekna The dual role of astrocyte activation and reactive gliosis Neurosci. Lett. 565 2014 30 38
151. 7 improves recovery after spinal cord injury Proc. Natl. Acad. Sci. U. S. A. 106 2009 12489 12493
152. G. Perea, and A. Araque GLIA modulates synaptic transmission Brain Res. Rev. 63 2010 93 102
153. G. Perea, M. Navarrete, and A. Araque Tripartite synapses: astrocytes process and control synaptic information Trends Neurosci. 32 2009 421 431
154. A. Pereira Jr., and F.A. Furlan Astrocytes and human cognition: modeling information integration and modulation of neuronal activity Prog. Neurobiol. 92 2010 405 420
155. C. Quintas, S. Fraga, J. Goncalves, and G. Queiroz P2Y receptors on astrocytes and microglia mediate opposite effects in astroglial proliferation Purinergic Signal 7 2011 251 263
156. G. Rajkowska, J.J. Miguel-Hidalgo, Z. Makkos, H. Meltzer, J. Overholser, and C. Stockmeier Layer-specific reductions in GFAP-reactive astroglia in the dorsolateral prefrontal cortex in schizophrenia Schizophr. Res. 57 2002 127 138
157. G. Rajkowska, L.D. Selemon, and P.S. Goldman-Rakic Neuronal and glial somal size in the prefrontal cortex: a postmortem morphometric study of schizophrenia and Huntington disease Arch. Gen. Psychiatry 55 1998 215 224
158. G. Rajkowska, and C.A. Stockmeier Astrocyte pathology in major depressive disorder: insights from human postmortem brain tissue Curr. Drug Targets 14 2013 1225 1236
159. K.V. Rama Rao, and M.D. Norenberg Glutamine in the pathogenesis of hepatic encephalopathy: the trojan horse hypothesis revisited Neurochem. Res. 39 2014 593 598
160. V. Rangroo Thrane, A.S. Thrane, F. Wang, M.L. Cotrina, N.A. Smith, M. Chen, Q. Xu, N. Kang, T. Fujita, E.A. Nagelhus, and M. Nedergaard Ammonia triggers neuronal disinhibition and seizures by impairing astrocyte potassium buffering Nat. Med. 19 2013 1643 1648
161. K.J. Reissner, and P.W. Kalivas Using glutamate homeostasis as a target for treating addictive disorders Behav. Pharmacol. 21 2010 514 522
162. S. Robel, B. Berninger, and M. Gotz The stem cell potential of glia: lessons from reactive gliosis Nat. Rev. Neurosci. 12 2011 88 104
163. J.M. Robertson Astrocyte domains and the three-dimensional and seamless expression of consciousness and explicit memories Med. Hypotheses 81 2013 1017 1024
164. C.F. Rose, A. Verkhratsky, and V. Parpura Astrocyte glutamine synthetase: pivotal in health and disease Biochem. Soc. Trans. 41 2013 1518 1524
165. C.A. Ross, E.H. Aylward, E.J. Wild, D.R. Langbehn, J.D. Long, J.H. Warner, R.I. Scahill, B.R. Leavitt, J.C. Stout, J.S. Paulsen, R. Reilmann, P.G. Unschuld, A. Wexler, R.L. Margolis, and S.J. Tabrizi Huntington disease: natural history, biomarkers and prospects for therapeutics Nat. Rev. Neurol. 10 2014 204 216
166. D. Rossi Astrocyte physiopathology: at the crossroads of intercellular networking, inflammation and cell death Prog. Neurobiol. 130 2015 86 120
167. D. Rossi, L. Brambilla, C.F. Valori, C. Roncoroni, A. Crugnola, T. Yokota, D.E. Bredesen, and A. Volterra Focal degeneration of astrocytes in amyotrophic lateral sclerosis Cell Death Differ. 15 2008 1691 1700
168. J.D. Rothstein, M. Dykes-Hoberg, C.A. Pardo, L.A. Bristol, L. Jin, R.W. Kuncl, Y. Kanai, M.A. Hediger, Y. Wang, J.P. Schielke, and D.F. Welty Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate Neuron 16 1996 675 686
169. M. Rubinov, and E. Bullmore Schizophrenia and abnormal brain network hubs Dialogues Clin. Neurosci. 15 2013 339 349
170. J.M. Ruckh, J.W. Zhao, J.L. Shadrach, P. van Wijngaarden, T.N. Rao, A.J. Wagers, and R.J. Franklin Rejuvenation of regeneration in the aging central nervous system Cell Stem Cell 10 2012 96 103
171. 7 receptor expression J. Immunol. 182 2009 4378 4385
172. T.P. Schnieder, and A.J. Dwork Searching for neuropathology: gliosis in schizophrenia Biol. Psychiatry 69 2011 134 139
173. R. Schwarcz, and C.A. Hunter Toxoplasma gondii and schizophrenia: linkage through astrocyte-derived kynurenic acid? Schizophr. Bull. 33 2007 652 653
174. A. Sequeira, F. Mamdani, C. Ernst, M.P. Vawter, W.E. Bunney, V. Lebel, S. Rehal, T. Klempan, A. Gratton, C. Benkelfat, G.A. Rouleau, N. Mechawar, and G. Turecki Global brain gene expression analysis links glutamatergic and GABAergic alterations to suicide and major depression PLoS One 4 2009 e6585
175. A. Serrano, N. Haddjeri, J.C. Lacaille, and R. Robitaille GABAergic network activation of glial cells underlies hippocampal heterosynaptic depression J. Neurosci. 26 2006 5370 5382
176. Y. Shinozaki, M. Nomura, K. Iwatsuki, Y. Moriyama, C. Gachet, and S. Koizumi Microglia trigger astrocyte-mediated neuroprotection via purinergic gliotransmission Sci. Rep. 4 2014 4329
177. 7 purinergic receptor: from physiology to neurological disorders FASEB J. 24 2010 337 345
178. M.V. Sofroniew Astrocyte barriers to neurotoxic inflammation Nat. Rev. Neurosci. 16 2015 249 263
179. M. Spangaro, M. Bosia, A. Zanoletti, M. Bechi, F. Cocchi, A. Pirovano, C. Lorenzi, P. Bramanti, F. Benedetti, E. Smeraldi, and R. Cavallaro Cognitive dysfunction and glutamate reuptake: effect of EAAT2 polymorphism in schizophrenia Neurosci. Lett. 522 2012 151 155
180. 7 receptor: an emerging target in central nervous system diseases Trends Pharmacol. Sci. 35 2014 537 547
181. K.A. Staats, and L. Van Den Bosch Astrocytes in amyotrophic lateral sclerosis: direct effects on motor neuron survival J. Biol. Phys. 35 2009 337 346
182. W.B. Stallcup The NG2 antigen, a putative lineage marker: immunofluorescent localization in primary cultures of rat brain Dev. Biol. 83 1981 154 165
183. S.O. Suadicani, R. Iglesias, J. Wang, G. Dahl, D.C. Spray, and E. Scemes ATP signaling is deficient in cultured Pannexin1-null mouse astrocytes Glia 60 2012 1106 1116
184. X. Sun, D. Salat, K. Upchurch, R. Deason, N. Kowall, A. Budson Alzheimer's Disease Neuroimaging Initiative Destruction of white matter integrity in patients with mild cognitive impairment and Alzheimer disease J. Investig. Med. 62 2014 927 933
185. N. Takahashi, and T. Sakurai Roles of glial cells in schizophrenia: possible targets for therapeutic approaches Neurobiol. Dis. 53 2013 49 60
186. 1 receptor stimulation decreases cerebral edema and reactive gliosis in a traumatic brain injury model J. Neurotrauma 30 2013 55 66
187. D. Thimm, M. Knospe, A. Abdelrahman, M. Moutinho, B.B. Alsdorf, I. von Kugelgen, A.C. Schiedel, and C.E. Muller Characterization of new G protein-coupled adenine receptors in mouse and hamster Purinergic Signal 9 2013 415 426
188. A. Thyssen, M. Stavermann, K. Buddrus, M. Doengi, J.A. Ekberg, J.A. St John, J.W. Deitmer, and C. Lohr Spatial and developmental heterogeneity of calcium signaling in olfactory ensheathing cells Glia 61 2013 327 337
189. G.S. Tomassy, and V. Fossati How big is the myelinating orchestra? Cellular diversity within the oligodendrocyte lineage: facts and hypotheses Front. Cell Neurosci. 8 2014 201
190. ir4.1 ion channel deficits contribute to neuronal dysfunction in Huntington's disease model mice Nat. Neurosci. 17 2014 694 703
191. H. Tozaki-Saitoh, M. Tsuda, and K. Inoue Role of purinergic receptors in CNS function and neuroprotection Adv. Pharmacol. 61 2011 495 528
192. E. Turola, R. Furlan, F. Bianco, M. Matteoli, and C. Verderio Microglial microvesicle secretion and intercellular signaling Front. Physiol. 3 2012 149
193. H. Ulrich, and P. Illes P2X receptors in maintenance and differentiation of neural progenitor cells Neural Regen. Res. 9 2014 2040 2041
194. C.F. Valori, L. Brambilla, F. Martorana, and D. Rossi The multifaceted role of glial cells in amyotrophic lateral sclerosis Cell Mol. Life Sci. 71 2014 287 297
195. A. Verkhratsky Physiology of neuronal-glial networking Neurochem. Int. 57 2010 332 343
196. A. Verkhratsky, and G. Burnstock Biology of purinergic signalling: its ancient evolutionary roots, its omnipresence and its multiple functional significance Bioessays 36 2014 697 705
197. A. Verkhratsky, and A.M. Butt Glial Physiology and Pathophysiology 2013 Wiley-Blackwell Chichester
198. A. Verkhratsky, O.A. Krishtal, and G. Burnstock Purinoceptors on neuroglia Mol. Neurobiol. 39 2009 190 208
199. A. Verkhratsky, A. Marutle, J.J. Rodriguez-Arellano, and A. Nordberg Glial asthenia and functional paralysis: a new perspective on neurodegeneration and Alzheimer's Disease Neuroscientist 2014 10.1177/1073858414547132 E-pub ahead of print
200. A. Verkhratsky, and M. Nedergaard Astroglial cradle in the life of the synapse Philos. Trans. R. Soc. Lond B Biol. Sci. 369 2014 20130595
201. A. Verkhratsky, M. Nedergaard, and L. Hertz Why are astrocytes important? Neurochem. Res. 40 2015 389 401
202. A. Verkhratsky, M. Olabarria, H.N. Noristani, C.Y. Yeh, and J.J. Rodriguez Astrocytes in Alzheimer's disease Neurotherapeutics 7 2010 399 412
203. A. Verkhratsky, V. Parpura, M. Pekna, M. Pekny, and M. Sofroniew Glia in the pathogenesis of neurodegenerative diseases Biochem. Soc. Trans. 42 2014 1291 1301
204. A. Verkhratsky, V. Parpura, and J.J. Rodriguez Where the thoughts dwell: the physiology of neuronal-glial "diffuse neural net" Brain Res. Rev. 66 2011 133 151
205. A. Verkhratsky, J.J. Rodriguez, and V. Parpura Astroglia in neurological diseases Future Neurol. 8 2013 149 158
206. A. Verkhratsky, J.J. Rodriguez, and V. Parpura Neuroglia in ageing and disease Cell Tissue Res. 357 2014 493 503
207. A. Verkhratsky, J.J. Rodriguez, and L. Steardo Astrogliopathology: a central element of neuropsychiatric diseases? Neuroscientist 20 2014 576 588
208. A. Verkhratsky, M.V. Sofroniew, A. Messing, N.C. deLanerolle, D. Rempe, J.J. Rodriguez, and M. Nedergaard Neurological diseases as primary gliopathies: a reassessment of neurocentrism ASN Neuro 4 2012 e00082
209. R. Virchow Die Cellularpathologie in ihrer Begründung auf physiologische and pathologische Gewebelehre Zwanzig Vorlesungen gehalten während der Monate Februar, März und April 1858 im pathologischen Institut zu Berlin 1858 August Hirschwald Berlin
210. C. Volonte, S. Apolloni, M.T. Carri, and N. D'Ambrosi ALS: focus on purinergic signalling Pharmacol. Ther. 132 2011 111 122
211. K.B. Walhovd, H. Johansen-Berg, and R.T. Karadottir Unraveling the secrets of white matter-bridging the gap between cellular, animal and human imaging studies Neuroscience 276 2014 2 13
212. D.D. Wang, and A. Bordey The astrocyte odyssey Prog. Neurobiol. 86 2008 342 367
213. v1.2 gene in astrocytes in primary cultures and in the in vivo brain Acta Physiol. (Oxf) 214 2015 261 274
214. 7 receptor expression in rat oligodendrocyte precursor cells after hypoxia ischemia Glia 57 2009 307 319
215. M. Weber, N. Scherf, T. Kahl, U.D. Braumann, P. Scheibe, J.P. Kuska, R. Bayer, A. Buttner, and H. Franke Quantitative analysis of astrogliosis in drug-dependent humans Brain Res. 1500 2013 72 87
216. 2 receptor Purinergic Signal 8 2012 559 578
217. M.R. Williams, T. Hampton, R.K. Pearce, S.R. Hirsch, O. Ansorge, M. Thom, and M. Maier Astrocyte decrease in the subgenual cingulate and callosal genu in schizophrenia Eur. Arch. Psychiatry Clin. Neurosci. 263 2013 41 52
218. K. Yamanaka, S.J. Chun, S. Boillee, N. Fujimori-Tonou, H. Yamashita, D.H. Gutmann, R. Takahashi, H. Misawa, and D.W. Cleveland Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis Nat. Neurosci. 11 2008 251 253
219. C.Y. Yeh, B. Vadhwana, A. Verkhratsky, and J.J. Rodriguez Early astrocytic atrophy in the entorhinal cortex of a triple transgenic animal model of Alzheimer's disease ASN Neuro 3 2011 271 279
220. Z. Yin, D. Milatovic, J.L. Aschner, T. Syversen, J.B. Rocha, D.O. Souza, M. Sidoryk, J. Albrecht, and M. Aschner Methylmercury induces oxidative injury, alterations in permeability and glutamine transport in cultured astrocytes Brain Res. 1131 2007 1 10
221. F. Zeidan-Chulia, A.B. Salmina, N.A. Malinovskaya, M. Noda, A. Verkhratsky, and J.C. Moreira The glial perspective of autism spectrum disorders Neurosci. Biobehav. Rev. 38 2014 160 172
222. J.M. Zhang, H.K. Wang, C.Q. Ye, W. Ge, Y. Chen, Z.L. Jiang, C.P. Wu, M.M. Poo, and S. Duan ATP released by astrocytes mediates glutamatergic activity-dependent heterosynaptic suppression Neuron 40 2003 971 982
223. Y. Zhang, and B.A. Barres Astrocyte heterogeneity: an underappreciated topic in neurobiology Curr. Opin. Neurobiol. 20 2010 588 594
224. 3R-dependent stimulation of astrocyte mitochondrial metabolism reduces and partially reverses ischemic neuronal damage in mouse J. Cereb. Blood Flow. Metab. 33 2013 600 611
225. W. Zheng, L.T. Watts, D.M. Holstein, S.I. Prajapati, C. Keller, E.H. Grass, C.A. Walter, and J.D. Lechleiter Purinergic receptor stimulation reduces cytotoxic edema and brain infarcts in mouse induced by photothrombosis by energizing glial mitochondria PLoS One 5 2010 e14401
226. Y. Zhou, and N.C. Danbolt GABA and glutamate transporters in brain Front. Endocrinol. (Lausanne) 4 2013 165
227. H. Zimmermann Purinergic signaling in neural development Semin. Cell Dev. Biol. 22 2011 194 204
228. H. Zimmermann, M. Zebisch, and N. Strater Cellular function and molecular structure of ecto-nucleotidases Purinergic Signal 8 2012 437 502
229. H.Y. Zoghbi, and H.T. Orr Glutamine repeats and neurodegeneration Annu. Rev. Neurosci. 23 2000 217 247
230. 2+ as a signalling route ASN Neuro 4 2012 e00080
231. R. Zorec, A. Verkhratsky, J.J. Rodriguez, and V. Parpura Astrocytic vesicles and gliotransmitters: slowness of vesicular release and synaptobrevin2-laden vesicle nanoarchitecture Neuroscience 2015 10.1016/j.neuroscience.2015.02.033 E-pub ahead of print